Administrative Core

行政核心

基本信息

  • 批准号:
    10696181
  • 负责人:
  • 金额:
    $ 25.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-13 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY – ADMINISTRATIVE CORE The overall goal of the Administrative Core (Admin Core) is to provide the organizational infrastructure necessary to stimulate research and to expedite the translation of discoveries into new and better treatments for glioblastoma (GBM). The Admin Core will facilitate these activities by providing leadership, financial management, and an administrative structure designed to efficiently coordinate the activities of the research projects, shared resources cores, the Glioblastoma Therapeutics Network (GTN), and the Network Coordination Center (NCC). In addition, the Admin Core incorporates a biostatistical component and will oversee all statistical support to all Projects and Cores. Specifically, the Admin Core will: 1) Provide leadership, organizational support, oversight of data management, and financial management for the U19 investigators; 2) Promote integration of the three projects to enhance interaction among the three participating institutions (City of Hope, University of Alabama at Birmingham and the Translational Genomics Research Institute), the internal advisory board (IAB) and other GTN U19 Research Centers; 3) Facilitate collaboration with other U19 Research Centers to fund and oversee pilot projects; 4) Serve as the liaison working with the NCC to implement network best practices and policies; and 5) Provide biostatistical expertise to support basic science, translational, and clinical research. The proposed U19 structure, consisting of three participating institutions, will be directed by Drs. Portnow (Contact PI) and Badie (MPI) at City of Hope. The members of this team are well acquainted and have a track record of collaborating on GBM research projects and leading the City of Hope Brain Tumor Program. Through performance of the Specific Aims, the Admin Core will ensure effective functioning of the U19 to maximize our efficiency, conserve resources, and expedite clinical development of novel therapies for GBM.
项目总结-行政核心

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jana Portnow其他文献

Jana Portnow的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jana Portnow', 18)}}的其他基金

Tasquinimod as an adjunct to immunotherapies administered peri-operatively
他喹莫德作为围手术期免疫治疗的辅助药物
  • 批准号:
    10488221
  • 财政年份:
    2021
  • 资助金额:
    $ 25.19万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10488201
  • 财政年份:
    2021
  • 资助金额:
    $ 25.19万
  • 项目类别:
Tasquinimod as an adjunct to immunotherapies administered peri-operatively
他喹莫德作为围手术期免疫治疗的辅助药物
  • 批准号:
    10306305
  • 财政年份:
    2021
  • 资助金额:
    $ 25.19万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10306301
  • 财政年份:
    2021
  • 资助金额:
    $ 25.19万
  • 项目类别:
Tasquinimod as an adjunct to immunotherapies administered peri-operatively
他喹莫德作为围手术期免疫治疗的辅助药物
  • 批准号:
    10696191
  • 财政年份:
    2021
  • 资助金额:
    $ 25.19万
  • 项目类别:

相似海外基金

HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
  • 批准号:
    2318404
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
  • 批准号:
    10552484
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
  • 批准号:
    10576701
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
  • 批准号:
    480914
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Australian Laureate Fellowships
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
  • 批准号:
    10517004
  • 财政年份:
    2022
  • 资助金额:
    $ 25.19万
  • 项目类别:
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
  • 批准号:
    22K02974
  • 财政年份:
    2022
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
UCSF - UCB TRAC Basic Science CORE
UCSF - UCB TRAC 基础科学核心
  • 批准号:
    10674711
  • 财政年份:
    2022
  • 资助金额:
    $ 25.19万
  • 项目类别:
Basic Science Core - Imaging
基础科学核心 - 成像
  • 批准号:
    10588228
  • 财政年份:
    2022
  • 资助金额:
    $ 25.19万
  • 项目类别:
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
  • 批准号:
    10431468
  • 财政年份:
    2022
  • 资助金额:
    $ 25.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了